New potency labelling of topical corticosteroids in the UK

被引：0
|
作者：
Moss, Celia [1 ,2 ]
Ardern-Jones, Michael [3 ,4 ]
机构：
[1] Birmingham Womens & Childrens NHS Fdn Trust, Dept Dermatol, Birmingham, England
[2] Univ Birmingham, Birmingham, England
[3] Univ Hosp Southampton NHS Fdn Trust, Dept Dermatol, Southampton, England
[4] UNIV SOUTHAMPTON, FAC MED, SOUTHAMPTON, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2025年
关键词：
D O I：
10.1093/bjd/ljaf028
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
From June 2025 all topical steroids licensed in the UK will be labelled on the container and packaging as 'Mild steroid', 'Moderate steroid', 'Strong steroid' or 'Very strong steroid'. The designation will match the legal pharmaceutical category. The British National Formulary has previously classified a few products differently and has now altered those designations to match the new labels.
引用
收藏
页数：2
相关论文
共 50 条
  • [31] TOPICAL CORTICOSTEROIDS
    PACE, WE
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1973, 108 (01) : 11 - 13
  • [32] TOPICAL CORTICOSTEROIDS
    ROBERTSON, DB
    MAIBACH, HI
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1982, 21 (02) : 59 - 67
  • [33] Potency labelling of clotting factors
    Hubbard, A.
    HAEMOPHILIA, 2012, 18 : 100 - 100
  • [34] Knowledge of potency and formulations of topical corticosteroids among drug vendors in the Federal Capital Territory of Nigeria
    Ibekwe P.U.
    Henshaw E.B.
    Okudo G.C.
    Drugs & Therapy Perspectives, 2018, 34 (11) : 522 - 527
  • [35] Cushing's Syndrome Induced by Misuse of Moderate- to High-Potency Topical Corticosteroids
    Coureau, Benedicte
    Bussieres, Jean-Francois
    Tremblay, Stephanie
    ANNALS OF PHARMACOTHERAPY, 2008, 42 (12) : 1903 - 1907
  • [36] Topical Treatments with Pimecrolimus, Tacrolimus and Medium- to High-Potency Corticosteroids, and Risk of Lymphoma
    Schneeweiss, Sebastian
    Doherty, Mike
    Zhu, Shao
    Funch, Donnie
    Schlienger, Raymond G.
    Fernandez-Vidaurre, Carlos
    Seeger, John D.
    DERMATOLOGY, 2009, 219 (01) : 7 - 21
  • [37] Topical corticosteroids and risk of new-onset diabetes
    Reactions Weekly, 2009, 1255 (1) : 4 - 4
  • [38] Topical corticosteroids in New Zealand: patient concerns and adherence
    Saavedra, C. E.
    Cheng, H. S.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 : 112 - 112
  • [39] Topical corticosteroids with topical cyclosporine A versus topical corticosteroids alone for immunological corneal graft rejection
    Marques, Raquel Esteves
    Leal, Ines
    Guerra, Paulo Silva
    Barao, Rafael Correia
    Quintas, Ana Miguel
    Rodrigues, Walter
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2022, 32 (03) : 1469 - 1481
  • [40] CHOICE OF TOPICAL CORTICOSTEROIDS
    MAIN, RA
    WHITE, MI
    PRACTITIONER, 1977, 219 (1312) : 456 - 460
12345